Emine Nur RİFAİOĞLU, Füsun AYDOĞAN, Bilge Bülbül ŞEN, Tuğba ŞEN, Özlem EKİZ

Investigation into the frequency of Helicobacter pylori infection with carbon 14 urea breath test in patients with vitiligo

Vitiligo is a common, acquired depigmenting skin disorder. The relationship between Helicobacter pylori (HP) infection and autoimmune dermatological disease has been previously reported. However, the frequency of HP infection in patients with vitiligo has not been reported. In this study, we aimed to investigate the frequency of HP infection with the carbon 14 (C14) urea breath test (UBT) in patients with vitiligo. Materials and methods: This study included 34 patients (18 males and 16 females) with vitiligo and 30 age- and sex-matched healthy controls. HP infection was diagnosed using the C14 UBT (Heliprobe). Statistical analysis was performed using SPSS 19. Results: The frequency of HP infection was 64.7% in the patient group and 33.3% in the control group according to the C14 UBT (chi-square test, P = 0.012). HP infection frequency is statistically significantly higher in patients with vitiligo. Conclusion: To the best of our knowledge, this is the first investigation of the frequency of HP positivity in patients with vitiligo. To better understand the role of HP in vitiligo as an etiological or initiating factor, further experimental and clinical studies with a greater number of patients are needed.

Anahtar Kelimeler:

Helicobacter pylori, carbon 14, urea breath test, vitiligo

Investigation into the frequency of Helicobacter pylori infection with carbon 14 urea breath test in patients with vitiligo

Keywords:

Helicobacter pylori, carbon 14, urea breath test, vitiligo,

PDF

___

Lee BW, Schwartz RA, Hercogova J, Valle Y, Lotti TM. Vitiligo road map. Dermatol Ther 2012; 25: S44–S56.
Kruger C, Schallreuter KU. A review of the worldwide prevalence of vitiligo in children/adolescents and adults. Int J Dermatol 2012; 51: 1206–1212.
Wu J, Zhou M, Wan Y, Xu A. CD8+ T cells from vitiligo perile- sional margins induce autologous melanocyte apoptosis. Mol Med Rep 2013; 7: 237–241.
Namazi MR. Neurogenic dysregulation, oxidative stress, autoimmunity, and melanocytorrhagy in vitiligo: can they be interconnected? Pigment Cell Res 2007; 20: 360–363.
Lin X, Tian H, Xianmin M. Possible roles of B lymphocyte activating factor of the tumour necrosis factor family in vitiligo autoimmunity. Med Hypotheses 2011; 76: 339–342.
Westerhof W, Manini P, Napolitano A, d’Ischia M. The haptenation theory of vitiligo and melanoma rejection: a close- up. Exp Dermatol 2011; 20: 92–96.
Metwalley KA, Farghaly HS. Hepatitis C virus infection in a child with autoimmune polyendocrine syndrome type 2: a case report. J Med Case Rep 2012; 6: 221.
Akbayir N, Gökdemir G, Mansur T, Sökmen M, Gündüz S, Alkim C, Barutcuoglu B, Erdem L. Is there any relationship between hepatitis C virus and vitiligo? J Clin Gastroenterol 2004; 38: 815–817.
Grimes PE, Sevall JS, Vojdani A. Cytomegalovirus DNA identified in skin biopsy specimens of patients with vitiligo. J Am Acad Dermatol 1996; 35: 21–26.
Porras C, Nodora J, Sexton R, Ferreccio C, Jimenez S, Domin- guez RL, Cook P, Anderson G, Morgan DR, Baker LH et al. Ep- idemiology of Helicobacter pylori infection in six Latin Ameri- can countries (SWOG Trial S0701). Cancer Causes Control 2013; 24: 209–215.
Mhaskar RS, Ricardo I, Azliyati A, Laxminarayan R, Amol B, Santosh W, Boo K. Assessment of risk factors of Helicobacter pylori infection and peptic ulcer disease. J Glob Infect Dis 2013; 5: 60–67.
Campuzano-Maya G. Cure of alopecia areata after eradication of Helicobacter pylori: a new association? World J Gastroenterol 2011; 17: 3165–3170.
Ersoy O, Ersoy R, Yayar O, Demirci H, Tatlican S. H pylori infection in patients with Behcet’s disease. World J Gastroenterol 2007; 13: 2983–2985.
Ben Mahmoud L, Ghozzi H, Hakim A, Sahnoun Z, Zeghal K. Helicobacter pylori associated with chronic urticaria. J Infect Dev Ctries 2011; 5: 596–598.
Neri S, Ierna D, D’Amico RA, Giarratano G, Leotta C. Helicobacter pylori and prurigo nodularis. Hepatogastroenterology 1999; 46: 2269–2272.
Onsun N, Arda Ulusal H, Su O, Beycan I, Biyik Ozkaya D, Senocak M. Impact of Helicobacter pylori infection on severity of psoriasis and response to treatment. Eur J Dermatol 2012; 22: 117–120.
El-Khalawany M, Mahmoud A, Mosbeh AS, Abd Alsalam F, Ghonaim N, Abou-Bakr A. Role of Helicobacter pylori in common rosacea subtypes: a genotypic comparative study of Egyptian patients. J Dermatol 2012; 39: 989–995.
Hernando-Harder AC, Booken N, Goerdt S, Singer MV, Harder H. Helicobacter pylori infection and dermatologic diseases. Eur J Dermatol 2009; 19: 431–444.
Hercogova J, Schwartz RA, Lotti TM. Classification of vitiligo: a challenging endeavor. Dermatol Ther 2012; 25: S10–S16.
Özdemir E, Karabacak NI, Değertekin B, Cırak M, Dursun A, Engin D, Ünal S, Ünlü M. Could the simplified (14)C urea breath test be a new standard in noninvasive diagnosis of Helicobacter pylori infection? Ann Nuc Med 2008; 22: 611–616.
Mishra S. Is Helicobacter pylori good or bad? Eur J Clin Microbiol Infect Dis 2013; 32: 301–304.
Suzuki H, Franceschi F, Nishizawa T, Gasbarrini A. Extragastric manifestations of Helicobacter pylori infection. Helicobacter 2011; 16: S65–S69.
Oztürk E, Yeşilova Z, Ilgan S, Arslan N, Erdil A, Celasun B, Ozgüven M, Dağalp K, Ovali O, Bayhan H. A new, practical, low-dose 14C-urea breath test for the diagnosis of Helicobacter pylori infection: clinical validation and comparison with the standard method. Eur J Nucl Med Mol Imaging 2003; 30: 1457–1462.
Türkölmez S, Cayir D, Aydoğan F, Korkmaz M. The relationship of Helicobacter pylori positivity with age, sex, and ABO/Rhesus blood groups in patients with gastrointestinal complaints in Turkey. Helicobacter 2007; 12: 244–250.
Magen E, Mishal J. Possible benefit from treatment of Helicobacter pylori in antihistamine-resistant chronic urticaria. Clin Exp Dermatol 2013; 38: 7–12.
Sadighha A, Shirali R, Zahed GM. Relationship between Helicobacter pylori and chronic urticaria. J Eur Acad Dermatol Venereol 2009; 23: 198–199.
Abdel-Hafez HZ, Mahran AM, Hofny ER, Attallah DA, Sayed DS, Rashed HA. Is Helicobacter pylori infection associated with alopecia areata? J Cosmet Dermatol 2009; 8: 52–55.
Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res 2003; 16: 208–214.
Akay BN, Bozkir M, Anadolu Y, Gullu S. Epidemiology of vitiligo, associated autoimmune diseases and audiological abnormalities: Ankara study of 80 patients in Turkey. J Eur Acad Dermatol Venereol 2010; 24: 1144–1150.
van Eden W, Koets A, van Kooten P, Prakken B, van der Zee R. Immunopotentiating heat shock proteins: negotiators between innate danger and control of autoimmunity. Vaccine 2003; 21: 897–901.